{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-057617","form_type":"8-K/A","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2026-08-18T18:03:52+00:00","discovered_at":"2026-08-18T18:05:00.461403+00:00","generated_at":"2026-08-18T18:05:06.038701+00:00","sec_items":["2.02","9.01","8.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Iradimed Q2 revenue flat at $20.5M, EPS down 9% to $0.41; reaffirms FY guidance","bullets":["Q2 revenue $20.5M, up 0.5% YoY; GAAP EPS $0.41, down 9%; non-GAAP EPS $0.46, down 7%.","Net income $5.2M, down 10% YoY; gross margin 74% vs 78% prior year.","Declares $0.20/share quarterly dividend, payable Aug 28, 2026, record Aug 14, 2026.","Reaffirms FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP $2.09-2.24.","New 3870 MR IV pump launch underway; >70% of new pump orders for quad stack configuration."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-057617","json":"https://secwatch.observer/filing/0001628280-26-057617.json","markdown":"https://secwatch.observer/filing/0001628280-26-057617.md","text":"https://secwatch.observer/filing/0001628280-26-057617.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000162828026057617/0001628280-26-057617-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000162828026057617/irmd-20260731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T18:05:06.038701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}